Professor Yasmine Belkaid
launches the Pasteur 2030 Strategy
We are delighted to share with you the new strategic plan of the Institut Pasteur 'Pasteur 2030', an ambitious roadmap to become a world leader in understanding human health and the fight against infectious disease.
​
The institute's founding mission; 'for research, for health, for the future', sits at the heart of this strategy, which also includes bold plans to take the institute even further.
Pasteur 2030
Strengthening it's role as the world's leading institute in research on living organisms, against infectious disease and for population health, the Institut Pasteur has developed an ambitious strategic plan for 2030 to meet the major scientific and health challenges of the coming years.
​
Under the leadership of Professor Yasmine Belkaid, Director General, and in coordination with all its collaborators, the Pasteur 2030 strategy seeks to advance our understanding of diseases, find solutions to combat them and share knowledge while defending the values of science.
​
Faced with the many risks to human health, such as infectious diseases, antibiotic resistance, aging, climate change, chronic inflammatory diseases, cancers which increasingly affect young people, and neurodegenerative diseases, the Institut Pasteur wishes to strengthen its role as the world's leading research organisation in understanding and combating these diseases by 2030.
One Ambition; Three Objectives
Pasteur 2030 seeks to:
1. Advance our understanding of infectious diseases, their role in the development of other conditions and the reactions they provoke in humans, by studying
(i) endemic infectious diseases and antibiotic resistance,
(ii) the risk of infections with pandemic potential, particularly in the context of global warming,
(iii) the causes of complex non-communicable and inflammatory diseases
(iv) specific human responses to diseases according to age, sex and biological context.
2. Find solutions to combat these diseases by
(i) discovering effective tests, vaccines and treatments against them,
(ii) monitoring the most virulent pathogens in circulation to prevent or even control epidemics and
(iii) detecting and treating patients in France (thanks to our medical center) and around the world (with the Pasteur Network).
3. Share our knowledge and defend our values ​​within society by
(i) training future generations of scientists,
(ii) defending the role of science in the face of attacks on it, and
(iii) promoting a humanist, inclusive and responsible vision of the world.
Four Scientific Priorities
Within these three key objectives, the Pasteur 2030 strategy will focus on four scientific priority areas. These are:
​
Infectious threats - Combating infectious diseases and resistance to antibiotics and other antimicrobial agents.
Environmental transitions and health - Understanding the impact of climate change and ecological transitions on health and disease.
The origins of disease - Studying the underlying mechanisms of non-communicable diseases and inflammation.
Health and disease at the extremes of life - Exploring the physiology and immune responses at key stages of life, including early development (with a focus on the mother-child relationship) and aging.
​
Through our partnerships with leading UK institutions, Pasteur Foundation - UK will be supporting the Pasteur 2030 strategy, with a focus on:
​
-
Sharing knowledge and defending our values, by training future generations of scientists through our Pasteur Foundation - UK young researcher mobility programme, which covers all scientific priority areas and promotion of our 'discovery partnerships' to bring French and British researchers together.
-
Advancing our understanding of infectious diseases, their role in the development of other conditions and the reactions they provoke in humans through our major research partnerships with leading UK institutions, with a particular focus on resistance to antibiotics and other antimicrobial agents, better understanding the mechanisms of non-communicable diseases and inflammation and understanding the impact of climate change and ecological transitions on health and disease.